JP2025501767A5 - - Google Patents
Info
- Publication number
- JP2025501767A5 JP2025501767A5 JP2024538383A JP2024538383A JP2025501767A5 JP 2025501767 A5 JP2025501767 A5 JP 2025501767A5 JP 2024538383 A JP2024538383 A JP 2024538383A JP 2024538383 A JP2024538383 A JP 2024538383A JP 2025501767 A5 JP2025501767 A5 JP 2025501767A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- alkyl
- diseases
- pharmaceutically acceptable
- stereoisomer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2021904206A AU2021904206A0 (en) | 2021-12-22 | Arylsulphonamide compounds | |
| AU2021904206 | 2021-12-22 | ||
| PCT/AU2022/051568 WO2023115142A1 (en) | 2021-12-22 | 2022-12-22 | Arylsulphonamide compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025501767A JP2025501767A (ja) | 2025-01-23 |
| JP2025501767A5 true JP2025501767A5 (https=) | 2025-12-22 |
Family
ID=86900817
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024538383A Pending JP2025501767A (ja) | 2021-12-22 | 2022-12-22 | アリールスルホンアミド化合物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250059188A1 (https=) |
| EP (1) | EP4452977A4 (https=) |
| JP (1) | JP2025501767A (https=) |
| KR (1) | KR20240150419A (https=) |
| CN (1) | CN118715222A (https=) |
| AU (1) | AU2022421952A1 (https=) |
| CA (1) | CA3241624A1 (https=) |
| MX (1) | MX2024007885A (https=) |
| WO (1) | WO2023115142A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4452978A4 (en) * | 2021-12-22 | 2025-12-17 | Anaxis Pharma Pty Ltd | BIFUNCTIONAL ARYLSULFONAMIDE COMPOUNDS |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7202363B2 (en) * | 2003-07-24 | 2007-04-10 | Abbott Laboratories | Thienopyridine and furopyridine kinase inhibitors |
| PE20061119A1 (es) * | 2005-01-19 | 2006-11-27 | Aventis Pharma Sa | PIRAZOLO PIRIDINAS SUSTITUIDAS COMO INHIBIDORES DE CINASAS FAK, KDR Y Tie |
| EP1683796A1 (en) * | 2005-01-24 | 2006-07-26 | Schering Aktiengesellschaft | Pyrazolopyridines, their preparation and their medical use |
| TW200815437A (en) * | 2006-06-13 | 2008-04-01 | Bayer Schering Pharma Ag | Substituted aminopyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| WO2018192416A1 (en) * | 2017-04-17 | 2018-10-25 | National Institute Of Biological Sciences, Beijing | Treating Male Senescence |
| DK4168401T3 (da) * | 2020-06-19 | 2026-04-13 | Anaxis Pharma Pty Ltd | Sulfonamidforbindelser |
| EP4452978A4 (en) * | 2021-12-22 | 2025-12-17 | Anaxis Pharma Pty Ltd | BIFUNCTIONAL ARYLSULFONAMIDE COMPOUNDS |
-
2022
- 2022-12-22 MX MX2024007885A patent/MX2024007885A/es unknown
- 2022-12-22 US US18/722,104 patent/US20250059188A1/en active Pending
- 2022-12-22 CA CA3241624A patent/CA3241624A1/en active Pending
- 2022-12-22 EP EP22908904.0A patent/EP4452977A4/en active Pending
- 2022-12-22 CN CN202280091908.0A patent/CN118715222A/zh active Pending
- 2022-12-22 JP JP2024538383A patent/JP2025501767A/ja active Pending
- 2022-12-22 KR KR1020247024225A patent/KR20240150419A/ko active Pending
- 2022-12-22 WO PCT/AU2022/051568 patent/WO2023115142A1/en not_active Ceased
- 2022-12-22 AU AU2022421952A patent/AU2022421952A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025501766A5 (https=) | ||
| JP6861703B2 (ja) | Ｔｇｒ５修飾物質およびその使用方法 | |
| JP6722178B2 (ja) | Ｗｎｔシグナル伝達経路の阻害剤としてのｎ−ピリジニルアセトアミド誘導体 | |
| EP2940019B1 (en) | SUBSTITUTED SPIROPYRIDO[1,2-a]PYRAZINE DERIVATIVE AND MEDICINAL USE THEREOF AS HIV INTEGRASE INHIBITOR | |
| JP6466348B2 (ja) | スルファモイル−アリールアミドおよびｂ型肝炎を処置するための医薬品としてのその使用 | |
| JP2025501765A5 (https=) | ||
| WO2021152149A1 (en) | Ras inhibitors and methods of using the same | |
| EP4161641A1 (en) | Lpa receptor antagonists and uses thereof | |
| TWI853704B (zh) | Lpa受體拮抗劑及其用途 | |
| CN107922377A (zh) | 乙肝病毒组装效应子 | |
| JP2007528417A5 (https=) | ||
| JP2025501767A5 (https=) | ||
| WO2022241023A1 (en) | Lpa receptor antagonists and uses thereof | |
| EP3753943A1 (en) | Heterocyclic compound, application thereof and pharmaceutical composition comprising same | |
| JP2018529745A5 (https=) | ||
| JP2023531709A5 (https=) | ||
| WO1999038867A1 (en) | 1-cycloalkyl-1,8-naphthyridin-4-one derivatives with phosphodiesterase iv inhibitory activity | |
| CN105646637A (zh) | 一种阿比特龙衍生物及其制备方法和医药用途 | |
| JP7159440B2 (ja) | ジカチオン化合物及びその製造方法と使用 | |
| CN110730777A (zh) | 作为atf4通路抑制剂的化学化合物 | |
| WO2024217531A1 (zh) | Cyp11a1抑制剂及其用途 | |
| JP2025513031A5 (https=) | ||
| TWI835476B (zh) | 哌嗪吲唑糖皮質素受體拮抗劑 | |
| IL299510A (en) | Atr inhibitors and uses thereof | |
| AU2005314601A1 (en) | Indane amides with antiproliferative activity |